These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2786292)

  • 1. Bioequivalence of two leucovorin calcium tablet formulations.
    De Vito JM; McGuire BW; De Lap RJ; Weiss AI
    DICP; 1989 Feb; 23(2):153-4. PubMed ID: 2786292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence of oral and injectable levoleucovorin and leucovorin.
    DeVito JM; Kozloski GD; Tonelli AP; Johnson JB
    Clin Pharm; 1993 Apr; 12(4):293-9. PubMed ID: 8458180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously.
    Priest DG; Schmitz JC; Bunni MA; Stuart RK
    J Natl Cancer Inst; 1991 Dec; 83(24):1806-12. PubMed ID: 1744924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of leucovorin calcium after intravenous, intramuscular, and oral administration.
    McGuire BW; Sia LL; Leese PT; Gutierrez ML; Stokstad EL
    Clin Pharm; 1988 Jan; 7(1):52-8. PubMed ID: 3257913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic comparison of leucovorin and levoleucovorin.
    Zittoun J; Tonelli AP; Marquet J; De Gialluly E; Hancock C; Yacobi A; Johnson JB
    Eur J Clin Pharmacol; 1993; 44(6):569-73. PubMed ID: 8405015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma kinetic study following oral administration of leucovorin tablets in patients with gastric cancer--influence of subtotal gastrectomy].
    Nashimoto A; Sasaki J; Akai S; Sato T; Inada S
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3747-54. PubMed ID: 2596859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption kinetics of orally administered leucovorin calcium.
    McGuire BW; Sia LL; Haynes JD; Kisicki JC; Gutierrez ML; Stokstad EL
    NCI Monogr; 1987; (5):47-56. PubMed ID: 3501546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Simultaneous determination of leucovorin and 5-methyl-tetrahydrofolate diastereoisomers in human plasma by high-performance liquid chromatography-tandem mass spectrometry coupled with ultrafiltration centrifugation-based pretreatment and its application to a pharmacokinetic study].
    Xu C; Hui W; Sun L; Gao Q; Zou Q
    Se Pu; 2019 Jun; 37(6):581-588. PubMed ID: 31152507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of food on the oral bioavailability of UFT and leucovorin in cancer patients.
    Damle B; Ravandi F; Kaul S; Sonnichsen D; Ferreira I; Brooks D; Stewart D; Alberts D; Pazdur R
    Clin Cancer Res; 2001 Mar; 7(3):517-23. PubMed ID: 11297242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of the stereoisomers of leucovorin during repeated oral dosing.
    Schilsky RL; Choi KE; Vokes EE; Guaspari A; Guarnieri C; Whaling S; Liebner MA
    Cancer; 1989 Mar; 63(6 Suppl):1018-21. PubMed ID: 2783878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bioavailability and kinetics of folinic acid in the pharmaceutical formulations of Rescuvolin and Ledervorin in healthy volunteers.
    Guelen PJ; Vree TB; de Vos D; Lamers K
    Biopharm Drug Dispos; 1988; 9(1):31-9. PubMed ID: 3257707
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of leucovorin (D,L-5-formyltetrahydrofolate) after intravenous injection and constant intravenous infusion.
    Straw JA; Newman EM; Doroshow JH
    NCI Monogr; 1987; (5):41-5. PubMed ID: 3501545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum distribution of citrovorum factor and 5-methyltetrahydrofolate following oral and im administration of calcium leucovorin in normal adults.
    Mehta BM; Gisolfi AL; Hutchison DJ; Nirenberg A; Kellick MG; Rosen G
    Cancer Treat Rep; 1978 Mar; 62(3):345-50. PubMed ID: 306284
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancer.
    Mader RM; Steger GG; Rizovski B; Sieder AE; Locker G; Gnant MF; Jakesz R; Rainer H
    Br J Clin Pharmacol; 1994 Mar; 37(3):243-8. PubMed ID: 8198932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of folic acid and its metabolites: a comparison with leucovorin.
    Schmitz JC; Stuart RK; Priest DG
    Clin Pharmacol Ther; 1994 May; 55(5):501-8. PubMed ID: 8181194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of low levels of the stereoisomers of leucovorin and 5-methyltetrahydrofolate in plasma using a coupled chiral-achiral high-performance liquid chromatographic system with post-chiral column peak compression.
    Lin SL; Jadaud P; Whitfield LR; Wainer IW
    J Chromatogr; 1990 Nov; 532(2):227-36. PubMed ID: 2084121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts.
    Houghton JA; Williams LG; de Graaf SS; Cheshire PJ; Rodman JH; Maneval DC; Wainer IW; Jadaud P; Houghton PJ
    Cancer Res; 1990 Jun; 50(12):3493-502. PubMed ID: 2140289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and pharmacokinetic evaluations of UFT plus oral leucovorin.
    Pazdur R
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):35-9. PubMed ID: 9348565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of leucovorin rescue using a new methotrexate-independent biochemical assay for leucovorin and N5-methyltetrahydrofolate.
    Hamel E; Johnson G; Glaubiger D
    Cancer Treat Rep; 1981; 65(7-8):545-53. PubMed ID: 7018678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.